Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dapiglutide

A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide

Zealand Pharma · Phase 1 · Completed · Enrollment 30

NCT06758583

EudraCT 2024-516901-21

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Dapiglutide 10 mg/mLn/rn/rn/rn/r
Dapiglutide 25 mg/mLn/rn/rn/rn/r

Not shown

  • Dapiglutide 10 mg/mL: endpoint not reported
  • Dapiglutide 25 mg/mL: endpoint not reported